Early Diagnosis of Pulmonary Nodules
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
This study is intended to determine the positive predictive value (PPV) and negative predictive value (NPV) of the multi-protein classifier based on the observed study prevalence of Non-Small Cell Lung Cancer (NSCLC) in the study participants.
| Condition |
|---|
|
Precancerous Conditions Carcinoma |
| Study Type: | Observational |
| Study Design: | Observational Model: Cohort Time Perspective: Prospective |
| Official Title: | Early Diagnosis of Pulmonary Nodules Using A Plasma Proteomic Classifier, Protocol Number 1001-12 |
- Incidence rate of adult patients diagnosed with Non-Small Cell Lung Cancer [ Time Frame: 2 years post enrollment ] [ Designated as safety issue: No ]Incidence rate of Non-Small Cell Lung Cancer as determined by histologic or cytologic diagnosis and/or radiographically stability at 2 years post enrollment.
Biospecimen Retention: Samples Without DNA
Blood samples
| Estimated Enrollment: | 1600 |
| Study Start Date: | October 2012 |
| Estimated Study Completion Date: | December 2014 |
| Estimated Primary Completion Date: | October 2014 (Final data collection date for primary outcome measure) |
Patients must present with previously non-diagnosted lung nodules as found on CT. There is no change to the typical standard of care that any of the investigating physicians and/or centers provide the patients enrolled in this study. The data from this study will not be used to diagnose cancer nor be used to influence treatment decisions for the study participants.
Eligibility| Ages Eligible for Study: | 50 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | Yes |
| Sampling Method: | Non-Probability Sample |
Subject undergoing evaluation for a lung nodule by a pulmonologist in a pulmonary or chest clinic, and/or by a thoracic surgeon at the time of enrollment
Inclusion Criteria:
- Age ≥ 50 years
- Smoking history ≥ 20 pack-years
- Subject undergoing diagnostic evaluation for a lung nodule
- Subject undergoing evaluation for a lung nodule by a pulmonologist, and/or by a thoracic surgeon
- Baseline CT scan identifying lung nodule performed within 60 days of subject enrollment
- Nodules identified by CT scan previously not followed
- Subject willing to provide informed consent for the collection of blood specimens
Exclusion Criteria:
- Nodule work-up at the time of enrollment eligibility indicates any prior attempted or completed diagnostic biopsy procedure, such as transthoracic needle aspiration, bronchoscopic biopsy or surgery
- A prior CT scan is available that previously identifies the same lung nodule under consideration for study inclusion on the most current CT scan; AND the prior CT scan was performed more than 60 days before the current CT scan, irrespective of the candidate nodule's radiographic characterization such as size, density or appearance
- Current diagnosis of any cancer
- Prior diagnosis of any cancer within 2 years of lung nodule detection, except for non-melanoma skin cancer
- Administration of blood products, e.g. packed red blood cells, fresh frozen plasma, or platelets, within 30 days of subject enrollment
- History of human immunodeficiency virus (HIV) or Hepatitis C
Contacts and Locations
Show 21 Study Locations| Study Director: | Kenneth Fang, MD | Integrated Diagnostics, Inc. |
More Information
No publications provided
| Responsible Party: | Integrated Diagnostics |
| ClinicalTrials.gov Identifier: | NCT01752114 History of Changes |
| Other Study ID Numbers: | 1001-12 |
| Study First Received: | November 30, 2012 |
| Last Updated: | April 24, 2013 |
| Health Authority: | United States: Quorum Review IRB |
Keywords provided by Integrated Diagnostics:
|
Precancerous conditions Carcinoma |
Additional relevant MeSH terms:
|
Carcinoma Precancerous Conditions Neoplasms, Glandular and Epithelial Neoplasms by Histologic Type Neoplasms |
ClinicalTrials.gov processed this record on May 23, 2013